Market Overview

36 Healthcare Stocks Moving In Wednesday's After-Market Session

Share:

Gainers

Innovate, Inc. (NASDAQ:INNT) stock surged 29.2% to $0.85 during Wednesday's after-market session.

Genprex, Inc. (NASDAQ:GNPX) shares moved upwards by 14.8% to $2.17.

Alector, Inc. (NASDAQ:ALEC) shares surged 11.2% to $25.50. The most recent rating by BTIG, on November 21, is at Buy, with a price target of $28.00.

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) stock moved upwards by 6.4% to $0.21.

Solid Biosciences, Inc. (NASDAQ:SLDB) stock rose 5.9% to $3.95. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.

Sierra Oncology, Inc. (NASDAQ:SRRA) stock rose 5.8% to $0.37. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20.

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stock rose 5.8% to $2.38. The most recent rating by H.C. Wainwright, on January 10, is at Buy, with a price target of $6.00.

Achieve Life Sciences, Inc. (NASDAQ:ACHV) stock increased by 5.5% to $0.63.

Unum Therapeutics, Inc. (NASDAQ:UMRX) stock rose 5.0% to $1.25. The most recent rating by Morgan Stanley, on November 27, is at Overweight, with a price target of $3.00.

Affimed, Inc. (NASDAQ:AFMD) stock increased by 4.5% to $3.03.

Osmotica Pharmaceuticals, Inc. (NASDAQ:OSMT) stock increased by 4.3% to $6.99.

Organovo Holdings, Inc. (NASDAQ:ONVO) stock increased by 4.3% to $0.38.

Precipio, Inc. (NASDAQ:PRPO) stock surged 4.3% to $2.20. The most recent rating by Maxim Group, on November 22, is at Buy, with a price target of $4.00.

Neurotrope, Inc. (NASDAQ:NTRP) stock increased by 4.2% to $1.48.

InMode, Inc. (NASDAQ:INMD) stock surged 4.1% to $48.05. The most recent rating by Roth Capital, on December 19, is at Buy, with a price target of $13.00.

Teligent, Inc. (NASDAQ:TLGT) shares increased by 3.6% to $0.43.

MannKind, Inc. (NASDAQ:MNKD) stock surged 3.5% to $1.75. According to the most recent rating by Oppenheimer, on December 24, the current rating is at Outperform.

Akerna, Inc. (NASDAQ:KERN) shares increased by 3.5% to $8.82.

Nektar Therapeutics, Inc. (NASDAQ:NKTR) stock surged 3.3% to $22.87. The most recent rating by JP Morgan, on November 13, is at Neutral, with a price target of $28.00.

Oncolytics Biotech, Inc. (NASDAQ:ONCY) stock increased by 3.3% to $3.46.

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock increased by 3.2% to $3.89. According to the most recent rating by Gabelli & Co., on December 11, the current rating is at Hold.

Baudax Bio, Inc. (NASDAQ:BXRX) stock moved upwards by 3.2% to $8.80.

HEXO, Inc. (NYSE:HEXO) stock rose 3.1% to $1.48.

Jaguar Health, Inc. (NASDAQ:JAGX) shares increased by 3.0% to $0.85. The most recent rating by H.C. Wainwright, on November 18, is at Buy, with a price target of $3.00.

 

Losers

Tetraphase Pharmaceutical, Inc. (NASDAQ:TTPH) stock fell 23.2% to $2.95 during Wednesday's after-market session. The most recent rating by Gabelli & Co., on October 31, is at Buy, with a price target of $5.00.

Karuna Therapeutics, Inc. (NASDAQ:KRTX) shares plummeted 12.1% to $101.35. The most recent rating by Wells Fargo, on January 22, is at Overweight, with a price target of $137.00.

Dare Bioscience, Inc. (NASDAQ:DARE) shares declined 11.8% to $1.50.

Trillium Therapeutics, Inc. (NASDAQ:TRIL) shares fell 10.6% to $2.92.

Option Care Health, Inc. (NASDAQ:BIOS) shares declined 8.0% to $4.01.

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) stock fell 5.3% to $12.40.

Midatech Pharma, Inc. (NASDAQ:MTP) stock decreased by 5.1% to $0.84.

Axonics Modulation Tech, Inc. (NASDAQ:AXNX) shares plummeted 4.8% to $30.02. The most recent rating by SunTrust Robinson Humphrey, on January 08, is at Buy, with a price target of $38.00.

Biocept, Inc. (NASDAQ:BIOC) stock decreased by 3.5% to $0.33.

vTv Therapeutics, Inc. (NASDAQ:VTVT) shares declined 3.5% to $2.50.

Xenon Pharmaceuticals, Inc. (NASDAQ:XENE) stock plummeted 3.5% to $16.25. According to the most recent rating by William Blair, on January 08, the current rating is at Outperform.

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares decreased by 3.3% to $0.32.

Posted-In: Healthcare Stocks After-Market MoversAfter-Hours Center Markets Movers Trading Ideas

 

Related Articles (AFMD + ACHV)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com